FI113861B - Parannettu menetelmä 6,9-bis[(2-aminoetyyli)amino]bentso[g]-isokinoliini-5,10-dionin ja sen dimaleaattisuolan syntetisoimiseksi - Google Patents

Parannettu menetelmä 6,9-bis[(2-aminoetyyli)amino]bentso[g]-isokinoliini-5,10-dionin ja sen dimaleaattisuolan syntetisoimiseksi Download PDF

Info

Publication number
FI113861B
FI113861B FI963864A FI963864A FI113861B FI 113861 B FI113861 B FI 113861B FI 963864 A FI963864 A FI 963864A FI 963864 A FI963864 A FI 963864A FI 113861 B FI113861 B FI 113861B
Authority
FI
Finland
Prior art keywords
dione
isoquinoline
amino
bis
benzo
Prior art date
Application number
FI963864A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963864A (fi
FI963864A0 (fi
Inventor
Silvano Spinelli
Roberto Didomenico
Original Assignee
Novuspharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa filed Critical Novuspharma Spa
Publication of FI963864A publication Critical patent/FI963864A/fi
Publication of FI963864A0 publication Critical patent/FI963864A0/fi
Application granted granted Critical
Publication of FI113861B publication Critical patent/FI113861B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/08—Aza-anthracenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
FI963864A 1994-03-28 1996-09-27 Parannettu menetelmä 6,9-bis[(2-aminoetyyli)amino]bentso[g]-isokinoliini-5,10-dionin ja sen dimaleaattisuolan syntetisoimiseksi FI113861B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/220,007 US5506232A (en) 1994-03-28 1994-03-28 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
US22000794 1994-03-28
IB9500230 1995-03-27
PCT/IB1995/000230 WO1995026189A1 (en) 1994-03-28 1995-03-27 AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS[(2-AMINOETHYL)AMINO]BENZO[g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT

Publications (3)

Publication Number Publication Date
FI963864A FI963864A (fi) 1996-09-27
FI963864A0 FI963864A0 (fi) 1996-09-27
FI113861B true FI113861B (fi) 2004-06-30

Family

ID=22821665

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963864A FI113861B (fi) 1994-03-28 1996-09-27 Parannettu menetelmä 6,9-bis[(2-aminoetyyli)amino]bentso[g]-isokinoliini-5,10-dionin ja sen dimaleaattisuolan syntetisoimiseksi

Country Status (24)

Country Link
US (3) US5506232A (ru)
EP (1) EP0752857B1 (ru)
JP (2) JP3151462B2 (ru)
KR (1) KR100224153B1 (ru)
CN (2) CN1130199C (ru)
AT (1) ATE203408T1 (ru)
AU (1) AU679627B2 (ru)
BR (1) BR9507257A (ru)
CA (1) CA2186485C (ru)
CZ (2) CZ598A3 (ru)
DE (1) DE69521887T2 (ru)
DK (1) DK0752857T3 (ru)
ES (1) ES2159313T3 (ru)
FI (1) FI113861B (ru)
GR (1) GR3037014T3 (ru)
HU (1) HU223311B1 (ru)
LU (1) LU92089I2 (ru)
NO (2) NO307564B1 (ru)
NZ (1) NZ282480A (ru)
PT (1) PT752857E (ru)
RU (1) RU2144028C1 (ru)
TW (1) TW397826B (ru)
WO (1) WO1995026189A1 (ru)
ZA (1) ZA952477B (ru)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
SK281254B6 (sk) * 1995-07-13 2001-01-18 Smithkline Beecham Corporation Použitie@kán-2-propánamínu, farmaceutický prostriedok s jeho obsahom a jeho použitie
IT1315253B1 (it) * 1999-10-22 2003-02-03 Novuspharma Spa Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato
WO2005097128A1 (en) * 2004-03-30 2005-10-20 Novacea, Inc. 1,4-bis-n-oxide azaanthracenediones and the use thereof
US20080081041A1 (en) * 2006-09-29 2008-04-03 Jeffrey Nemeth Method of Using IL6 Antagonists with Mitoxantrone for Prostate Cancer
CN104513201B (zh) * 2013-09-28 2017-12-26 正大天晴药业集团股份有限公司 马来酸匹杉琼的结晶
CN104557704B (zh) * 2013-10-28 2017-05-10 北京凯莱天成医药科技有限公司 一种匹杉琼马来酸盐的制备方法
CN103787970A (zh) * 2014-01-14 2014-05-14 北京万全德众医药生物技术有限公司 一锅煮法制备6，9-二氟苯并异喹啉-5，10-二酮的工艺
CN110873765B (zh) * 2018-09-04 2022-05-17 北京凯莱天成医药科技有限公司 一种马来酸匹杉琼有关物质的检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920754A1 (en) * 1991-03-08 1992-09-09 Univ Vermont 6,9 BIS(SUBSTITUTED-AMINO) BENZO[g]-ISOQUINOLINE-5,10-DIONES
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt

Also Published As

Publication number Publication date
WO1995026189A1 (en) 1995-10-05
JP3151462B2 (ja) 2001-04-03
CA2186485A1 (en) 1995-10-05
NO964082L (no) 1996-09-27
NZ282480A (en) 1997-04-24
FI963864A (fi) 1996-09-27
HU9602655D0 (en) 1996-11-28
ZA952477B (en) 1996-09-27
HU223311B1 (hu) 2004-05-28
US5506232A (en) 1996-04-09
HUT75654A (en) 1997-05-28
PT752857E (pt) 2001-11-30
AU1958995A (en) 1995-10-17
JP3548099B2 (ja) 2004-07-28
DE69521887T2 (de) 2001-11-22
MX9603994A (es) 1997-12-31
NO2012020I2 (no) 2013-11-11
US5616709A (en) 1997-04-01
CZ285139B6 (cs) 1999-05-12
CN1130199C (zh) 2003-12-10
GR3037014T3 (en) 2002-01-31
RU2144028C1 (ru) 2000-01-10
CA2186485C (en) 1999-12-14
LU92089I2 (fr) 2012-12-27
CN1282738A (zh) 2001-02-07
NO964082D0 (no) 1996-09-27
TW397826B (en) 2000-07-11
ATE203408T1 (de) 2001-08-15
JP2001089454A (ja) 2001-04-03
CZ284937B6 (cs) 1999-04-14
DK0752857T3 (da) 2001-09-24
NO2012020I1 (no) 2012-12-27
CZ598A3 (cs) 1999-05-12
NO307564B1 (no) 2000-04-25
EP0752857B1 (en) 2001-07-25
CZ276796A3 (en) 1997-02-12
AU679627B2 (en) 1997-07-03
JPH09507674A (ja) 1997-08-05
DE69521887D1 (de) 2001-08-30
CN1145028A (zh) 1997-03-12
KR100224153B1 (ko) 1999-10-15
EP0752857A1 (en) 1997-01-15
ES2159313T3 (es) 2001-10-01
US5717099A (en) 1998-02-10
FI963864A0 (fi) 1996-09-27
BR9507257A (pt) 1997-10-07

Similar Documents

Publication Publication Date Title
FI86421C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 9-amino-1,2,3,4-tetrahydroakridin-1-oler.
CA2736097C (en) Carbazole compounds for inhibition of nf-kb activity
FI113861B (fi) Parannettu menetelmä 6,9-bis[(2-aminoetyyli)amino]bentso[g]-isokinoliini-5,10-dionin ja sen dimaleaattisuolan syntetisoimiseksi
CN113956256B (zh) 苦参碱d环结构改造的衍生物及其在制备抗肿瘤药物中的应用
EP1646388A2 (en) Cytotoxic indeno and isoindoloisoquinolones
EP0264124B1 (en) Quinoline base compound, process for the preparation thereof and anticancer agent containing the same as pharmacologically efficacious component
NL8001289A (nl) Pyrimidinederivaten, werkwijze voor het bereiden daar- van alsmede daaruit bereide farmaceutische preparaten.
EP1499595B1 (en) Amonafide salts
Tatibouët et al. Reaction of 3-amino-acridine with formaldehyde in acidic medium: Influence of the stoechiometry on the reaction products
MXPA96003994A (en) An improved method of synthesis for 6,9-bis [(2-aminoethyl) amino] benzo [g] -isoquinolin-5, 10-diona and its dimale salt
PL188075B1 (pl) Rozpuszczalne w wodzie C-pierścieniowe analogi 20(S)-kamptotecyny, kompozycja farmaceutyczna zawierająca te związki, ich zastosowanie oraz sposób wytwarzania
EP0487930A1 (en) Process for preparing benzo[C]phenanthridinium derivatives, and novel compounds prepared by said process
AU634654B2 (en) Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
US4521423A (en) 7,8,9,10-Tetrahydrobenzo[h]quinolin-9-amine derivatives and compositions and methods for treating depression employing them
KR840000053B1 (ko) 안트라퀴논 유도체의 제조방법
AU608300B2 (en) Substituted 9-amino-tetrahydroacridines and related compounds, a process for their preparation and their use as medicaments
JP2840796B2 (ja) 新規な縮合インダン誘導体及びその薬学的に許容される塩
US6248750B1 (en) 9-hydroxyamino tetrahydroacridine and related compounds
KR19990044614A (ko) 항암제로서의 2-[2-[(2-하이드록시에틸)아미노]에틸]-5-[(2-메틸아미노)에틸]아미노]인다졸로[4,3-ｇｈ]이소퀴놀린-6(2Ｈ)-온
CN118271331A (zh) 钩吻素子衍生物、合成方法及在抑制肿瘤细胞增殖中的应用
Křepelka et al. Syntheses and antineoplastic effects of some N-substituted imides of 1-substituted 4-aryl-naphthalene-2, 3-dicarboxylic acids
JPH01131161A (ja) Ｎ−〔置換アルキリデン〕融合−ビシクロアルキリデン及びヘテロアルキリデンキノリンアミン
Levine et al. Pyrimido [5, 4‐b] quinolines. II. Reactions at the heterocyclic ring‐carbon and nitrogen atoms
ITMI971851A1 (it) Derivati di ammino-acridine carbossiammidi aventi attivita' antitumorale

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: CELL THERAPEUTICS, INC.

SPCF Supplementary protection certificate application filed

Spc suppl protection certif: C20120036

SPCG Supplementary protection certificate granted

Spc suppl protection certif: 375

Extension date: 20200327

PC Transfer of assignment of patent

Owner name: CTI BIOPHARMA CORP.

MA Patent expired